Phase 3 Study to Evaluate Safety and Efficacy of Iclaprim Versus Vancomycin for ABSSSI: REVIVE-2

Clinical trial NCT02607618 · COMPLETED

Trial details

NCT number: NCT02607618
Sponsor: Motif Bio
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Skin Structures and Soft Tissue Infections

Start date: 2015-11-01
Primary completion: 2017-08-08
Enrollment: 613

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.